Clinical trials
Recruiting Urogenital Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Astellas Pharma Global Development, Inc. | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of California, Irvine | 2 |
| Wake Forest University Health Sciences | 2 |
| Blue Earth Therapeutics Ltd | 1 |
| Janssen Research & Development, LLC | 1 |
| Johns Hopkins University | 1 |
| K36 Therapeutics, Inc. | 1 |
| Marengo Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 23 |
| Breast Neoplasms | 8 |
| Neoplasms | 8 |
| Prostatic Neoplasms | 8 |
| Lung Neoplasms | 7 |
| Neoplasms by Site | 7 |
| Head and Neck Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Urinary Bladder Neoplasms | 6 |
| Gastrointestinal Neoplasms | 5 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.